Schizophrenia News and Research RSS Feed - Schizophrenia News and Research

Schizophrenia is a chronic debilitating disorder which affects more than two million Americans, and millions more worldwide. While significant progress has been made in understanding the disease and developing treatments, there remains a significant unmet medical need. More than 50% of patients switch their medication in a given year due to either poor response or the experience of adverse events.
Level of salts in the brain play critical role in controlling sleep-wake cycle

Level of salts in the brain play critical role in controlling sleep-wake cycle

Danish research is behind a new epoch-making discovery, which may prove decisive to future brain research. The level of salts in the brain plays a critical role in whether we are asleep or awake. This discovery may be of great importance to research on psychiatric diseases such as schizophrenia and convulsive fits from lack of sleep as well as post-anaesthetization confusion, according to Professor Maiken Nedergaard. [More]
Elusive brain receptor may play vital role in death of neurons from neurological diseases

Elusive brain receptor may play vital role in death of neurons from neurological diseases

Strokes, seizures, traumatic brain injury and schizophrenia: these conditions can cause persistent, widespread acidity around neurons in the brain. But exactly how that acidity affects brain function isn't well understood. [More]
Key gene changes reveal four previously unknown conditions within schizophrenia

Key gene changes reveal four previously unknown conditions within schizophrenia

Changes in key genes clearly define four previously unknown conditions within the umbrella diagnosis of schizophrenia, according to a study led by researchers from NYU Langone Medical Center published online April 28 in EBioMedicine, a Lancet journal. Cases associated with changes in each of the four genes were different from each other in terms of symptoms, intelligence level and other disease features. [More]
Group of gamma-protocadherins linked with neurons help regulate growth of dendrites

Group of gamma-protocadherins linked with neurons help regulate growth of dendrites

When you think of a neuron, imagine a tree. A healthy brain cell indeed looks like a tree with a full canopy. There's a trunk, which is the cell's nucleus; there's a root system, embodied in a single axon; and there are the branches, called dendrites. [More]
Study reveals new function for CACNA1C gene in psychiatric diseases

Study reveals new function for CACNA1C gene in psychiatric diseases

A new study shows the death of newborn brain cells may be linked to a genetic risk factor for five major psychiatric diseases, and at the same time shows a compound currently being developed for use in humans may have therapeutic value for these diseases by preventing the cells from dying. [More]
Single season of contact sports can cause measurable brain changes

Single season of contact sports can cause measurable brain changes

Repeated impacts to the heads of high school football players cause measurable changes in their brains, even when no concussion occurs, according to research from UT Southwestern Medical Center's Peter O'Donnell Jr. Brain Institute and Wake Forest University School of Medicine. [More]
Under-expressed miR-9 gene may contribute to schizophrenia risk

Under-expressed miR-9 gene may contribute to schizophrenia risk

By turning skin cells into brain neurons, researchers at the Icahn School of Medicine at Mount Sinai have identified that certain tiny molecules aiding in gene expression, known as microRNAs (miRNAs), are under-expressed in the brains of the 14 schizophrenia patients they studied. Their findings, published online today in the journal Cell Reports, show that one of these molecules, a miRNA known as miR-9, is a risk factor that controls the activity of hundreds of genes. [More]
Scientists identify genetic variants that may influence wellbeing, depression and neuroticism

Scientists identify genetic variants that may influence wellbeing, depression and neuroticism

An international group of more than 190 scientists who analyzed the genomes of 298,420 individuals have found genetic variants that may influence our sense of wellbeing, depression and neuroticism. [More]
Research finds high prevalence of smoking, low cessation rates in people with schizophrenia

Research finds high prevalence of smoking, low cessation rates in people with schizophrenia

Smoking addiction in schizophrenia can be explained by significantly increased activation of the ventro-medial prefrontal cortex (vmPFC), a region involved in the brain reward system. These new data, the result of a study by researchers at the Institut universitaire en santé mentale de Montréal and the University of Montreal confirms the tendency to smoke and low smoking cessation rates of people with schizophrenia. [More]
Heavy marijuana use may lead to lower dopamine release in the brain

Heavy marijuana use may lead to lower dopamine release in the brain

In a recent study, researchers found evidence of a compromised dopamine system in heavy users of marijuana. Lower dopamine release was found in the striatum - a region of the brain that is involved in working memory, impulsive behavior, and attention. Previous studies have shown that addiction to other drugs of abuse, such as cocaine and heroin, have similar effects on dopamine release, but such evidence for cannabis was missing until now. [More]
New classifier method may improve diagnosis of autism spectrum disorders

New classifier method may improve diagnosis of autism spectrum disorders

Many doctors and scientists think they could improve the diagnosis and understanding of autism spectrum disorders if they had reliable means to identify specific abnormalities in the brain. [More]
Coronary heart disease, cancer less likely among people with learning disabilities

Coronary heart disease, cancer less likely among people with learning disabilities

Coronary heart disease and cancer rates among people with learning disabilities are nearly a third lower than the general population, says new research. [More]
Glial cells can modulate specific nerve endings in the brain, find Rockefeller scientists

Glial cells can modulate specific nerve endings in the brain, find Rockefeller scientists

More than half of our brains are made up of glial cells, which wrap around nerve fibers and insulate them--similarly to how the plastic casing of an electric cable insulates the copper wire within--allowing electrical and chemical impulses to travel faster. [More]
Researchers identify severe side effects of Clozapine drug

Researchers identify severe side effects of Clozapine drug

Clozapine (CLZ) is a "gold standard" drug for managing treatment-resistant schizophrenia (TRS), who do not respond adequately to first-line antipsychotics. [More]
Physical, mental training may improve health of young schizophrenia patients

Physical, mental training may improve health of young schizophrenia patients

In as little as a few months, antipsychotic medications can tame the delusions and hallucinations that characterize schizophrenia. But the medications do little to reverse the less familiar brain-based problems that accompany the illness. [More]
Researchers identify blood-based biomarkers to accurately predict suicidal ideation in women

Researchers identify blood-based biomarkers to accurately predict suicidal ideation in women

Researchers have identified blood-based biomarkers and developed questionnaire-based apps that may help clinicians identify which of their female patients being treated for psychiatric disorders are at greatest risk of suicidal ideation or behavior. [More]
Janssen announces CHMP positive opinion for use of paliperidone palmitate 3-monthly injection for schizophrenia treatment

Janssen announces CHMP positive opinion for use of paliperidone palmitate 3-monthly injection for schizophrenia treatment

Janssen UK announced today that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the use of paliperidone palmitate 3-monthly injection for the maintenance treatment of schizophrenia in the European Union. [More]
Naltrexone injections could reduce risk of relapse among opioid dependent individuals

Naltrexone injections could reduce risk of relapse among opioid dependent individuals

In a multicenter, randomized clinical trial, ex-prisoners who received six monthly injections of naltrexone--a long-acting medication that blocks opioid receptors in the brain--were significantly less likely to resume opioid use than those who received counseling and referrals to community treatment centers without naltrexone. [More]
Lack of ARHGAP33 molecule causes neuropsychiatric disorders-related abnormal higher brain functions

Lack of ARHGAP33 molecule causes neuropsychiatric disorders-related abnormal higher brain functions

A research group led by Osaka University and the University of Tokyo found that the intracellular protein trafficking is important for higher brain functions such as learning and memory. The research group showed that a molecule, ARHGAP33 regulates synaptic functions and behaviors via intracellular protein trafficking and that the lack of ARHGAP33 causes neuropsychiatric disorder-related impaired higher brain functions. [More]
Defective PTCHD1 gene in brain creates symptoms associated with autism and ADHD

Defective PTCHD1 gene in brain creates symptoms associated with autism and ADHD

Evidence is mounting that a gene called PTCHD1 helps the brain sort between important sights and sounds — and distractions. This gene is active in a brain region that attaches more attention to a conversation with your boss, for instance, than to an air conditioner buzzing in the background. [More]
Advertisement
Advertisement